Institutional members access full text with Ovid®

Share this article on:

Pathological Excretion Patterns of Urinary Proteins in Miners Highly Exposed to Dinitrotoluene

Brüning, Thomas MD; Thier, Ricarda PhD; Mann, Helmut MD; Melzer, Heinrich PhD; Bröde, Peter Dipl-Math; Dallner, Gustav MD; Bolt, Hermann M. MD, PhD

Journal of Occupational and Environmental Medicine: July 2001 - Volume 43 - Issue 7 - p 610-615
Original Articles

A cohort of 161 underground miners who had been highly exposed to dinitrotoluene (DNT) in the copper-mining industry of the former German Democratic Republic was reinvestigated for signs of subclinical renal damage. The study included a screening of urinary proteins excreted by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and quantitations of the specific urinary proteins α1-microglobulin and glutathione-S-transferase α (GST α) as biomarkers for damage of the proximal tubule and glutathione-S-transferase π (GST π) for damage of the distal tubule. The exposures were categorized semiquantitatively (low, medium, high, and very high), according to the type and duration of professional contact with DNT. A straight dose-dependence of pathological protein excretion patterns with the semiquantitative ranking of DNT exposure was seen. Most of the previously reported cancer cases of the urinary tract, especially those in the higher exposed groups, were confined to pathological urinary protein excretion patterns. The damage from DNT was directed toward the tubular system. In many cases, the appearance of Tamm-Horsfall protein, a 105-kD protein marker, was noted. Data on the biomarkers α1-microglobulin, GST α, and GST π consistently demonstrated a dose-dependent increase in tubular damage, which confirmed the results of screening by SDS-PAGE and clearly indicated a nephrotoxic effect of DNT under the given conditions of exposure. Within the cluster of cancer patients observed among the DNT-exposed workers, only in exceptional cases were normal biomarker excretions found.

From the Institut für Arbeitsphysiologie an der Universität Dortmund (Dr Brüning, Dr Thier, Dr Bröde, Dr Bolt); the Medizinische Klinik II of the Rheinisch-Westfälische Technische Hochschule Aachen (Dr Mann, Dr Melzer); and the Clinical Center NOVUM, Huddinge, Karolinska Institute and University of Stockholm (Dr Dallner).

Address correspondence to: Thomas Brüning, MD, BGFA at the Ruhr-University, Buerkle-de-la-Camp-Platz 1, D-44789 Bochum, Germany; e-mail bruening@bgfa.de.

Copyright © by American College of Occupational and Environmental Medicine

© 2001 Lippincott Williams & Wilkins, Inc.